Impact of Extended Dosing Intervals and Ipsilateral Versus Contralateral Boosting on mRNA Vaccine Immunogenicity in Mice
Overall, our data provides insights into the immune mechanisms of action of mRNA-LNP to develop the optimal vaccine regimen for mRNA vaccine platforms.
Authors
- Sudha Chivukula (ORCID: https://orcid.org/0000-0002-1832-1465)
- W. L. Warren
- Gopinath Nageshwaran (ORCID: https://orcid.org/0000-0002-2682-381X)
- Hillary Danz
- Mona Motwani (ORCID: https://orcid.org/0000-0003-0912-5478)
- Sophie Ruiz (ORCID: https://orcid.org/0000-0002-1919-3100)
- Emilie Mausser (ORCID: https://orcid.org/0000-0001-5920-8808)
- Balaji Banoth (ORCID: https://orcid.org/0000-0002-7467-2198)
- Janhavi Nadkarni
- Bachra Rokbi
- Frank DeRosa
- Donghui Zhang (ORCID: https://orcid.org/0000-0001-7258-8577)
- Bin Lu (ORCID: https://orcid.org/0000-0001-7184-2211)
- Wei Zong (ORCID: https://orcid.org/0000-0002-7399-7687)
- Omkar Chaudhary
Institutions
- Sanofi (France) (FR)
- Sanofi (United States) (US)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-01
- DOI
- https://doi.org/10.3390/vaccines13030263
- Citations
- 1
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80